BH.IMMUN&BIO | MAKERS LAB. | BH.IMMUN&BIO/ MAKERS LAB. |
|||
---|---|---|---|---|---|
P/E (TTM) | x | -7.4 | -23.0 | - | View Chart |
P/BV | x | 1.5 | 1.2 | 125.1% | View Chart |
Dividend Yield | % | 0.0 | 0.0 | - |
BH.IMMUN&BIO MAKERS LAB. |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
BH.IMMUN&BIO Mar-23 |
MAKERS LAB. Mar-23 |
BH.IMMUN&BIO/ MAKERS LAB. |
5-Yr Chart Click to enlarge
|
||
High | Rs | 52 | 192 | 27.0% | |
Low | Rs | 21 | 96 | 21.3% | |
Sales per share (Unadj.) | Rs | 10.3 | 171.7 | 6.0% | |
Earnings per share (Unadj.) | Rs | -3.9 | -3.7 | 103.7% | |
Cash flow per share (Unadj.) | Rs | -3.8 | 3.5 | -109.6% | |
Dividends per share (Unadj.) | Rs | 0 | 0 | - | |
Avg Dividend yield | % | 0 | 0 | - | |
Book value per share (Unadj.) | Rs | 20.4 | 117.3 | 17.4% | |
Shares outstanding (eoy) | m | 43.18 | 5.90 | 731.9% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 3.5 | 0.8 | 416.9% | |
Avg P/E ratio | x | -9.4 | -38.8 | 24.2% | |
P/CF ratio (eoy) | x | -9.5 | 41.5 | -22.9% | |
Price / Book Value ratio | x | 1.8 | 1.2 | 144.0% | |
Dividend payout | % | 0 | 0 | - | |
Avg Mkt Cap | Rs m | 1,561 | 850 | 183.6% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 151 | 117 | 129.1% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 446 | 1,013 | 44.0% | |
Other income | Rs m | 11 | 23 | 46.6% | |
Total revenues | Rs m | 457 | 1,036 | 44.1% | |
Gross profit | Rs m | -161 | 33 | -483.6% | |
Depreciation | Rs m | 2 | 42 | 4.7% | |
Interest | Rs m | 71 | 22 | 321.5% | |
Profit before tax | Rs m | -223 | -8 | 2,654.1% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | -56 | 14 | -416.0% | |
Profit after tax | Rs m | -166 | -22 | 759.1% | |
Gross profit margin | % | -36.0 | 3.3 | -1,098.0% | |
Effective tax rate | % | 25.3 | -161.3 | -15.7% | |
Net profit margin | % | -37.3 | -2.2 | 1,723.7% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 358 | 633 | 56.5% | |
Current liabilities | Rs m | 940 | 275 | 341.5% | |
Net working cap to sales | % | -130.6 | 35.3 | -369.3% | |
Current ratio | x | 0.4 | 2.3 | 16.6% | |
Inventory Days | Days | 85 | 14 | 600.4% | |
Debtors Days | Days | 1,135 | 716 | 158.6% | |
Net fixed assets | Rs m | 1,262 | 890 | 141.9% | |
Share capital | Rs m | 432 | 59 | 731.9% | |
"Free" reserves | Rs m | 450 | 633 | 71.1% | |
Net worth | Rs m | 882 | 692 | 127.5% | |
Long term debt | Rs m | 0 | 43 | 0.0% | |
Total assets | Rs m | 1,620 | 1,523 | 106.4% | |
Interest coverage | x | -2.2 | 0.6 | -348.6% | |
Debt to equity ratio | x | 0 | 0.1 | 0.0% | |
Sales to assets ratio | x | 0.3 | 0.7 | 41.4% | |
Return on assets | % | -5.9 | 0 | -225,144.5% | |
Return on equity | % | -18.9 | -3.2 | 595.6% | |
Return on capital | % | -17.2 | 1.8 | -934.0% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 14.5 | 0 | - | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | 65 | NA | - | |
Fx inflow | Rs m | 0 | 0 | - | |
Fx outflow | Rs m | 65 | 2 | 2,745.5% | |
Net fx | Rs m | -65 | -2 | 2,745.5% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 109 | -86 | -126.4% | |
From Investments | Rs m | 5 | 13 | 36.9% | |
From Financial Activity | Rs m | -147 | 58 | -254.5% | |
Net Cashflow | Rs m | -34 | -16 | 211.7% |
Indian Promoters | % | 59.3 | 61.3 | 96.7% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 0.0 | 0.0 | - | |
FIIs | % | 0.0 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 40.8 | 38.7 | 105.2% | |
Shareholders | 34,910 | 4,176 | 836.0% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare BH.IMMUN&BIO With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | BH.IMMUN&BIO | MAKERS LAB. | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -2.05% | -1.27% | -0.44% |
1-Month | 6.88% | 15.48% | 2.15% |
1-Year | 21.09% | 25.74% | 49.82% |
3-Year CAGR | -9.20% | -16.55% | 14.21% |
5-Year CAGR | 28.29% | 21.72% | 19.19% |
* Compound Annual Growth Rate
Here are more details on the BH.IMMUN&BIO share price and the MAKERS LAB. share price.
Moving on to shareholding structures...
The promoters of BH.IMMUN&BIO hold a 59.3% stake in the company. In case of MAKERS LAB. the stake stands at 61.3%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of BH.IMMUN&BIO and the shareholding pattern of MAKERS LAB..
Finally, a word on dividends...
In the most recent financial year, BH.IMMUN&BIO paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.
MAKERS LAB. paid Rs 0.0, and its dividend payout ratio stood at -0.0%.
You may visit here to review the dividend history of BH.IMMUN&BIO, and the dividend history of MAKERS LAB..
For a sector overview, read our pharmaceuticals sector report.
After opening the day deep in red, Indian share markets reversed the trend as the session progressed and ended on firm footing.